NovoCure (NVCR) FCF Margin (2014 - 2026)
NovoCure's (NVCR) quarterly FCF Margin came in at 10.73% in Q1 2026, up 1913.0% year-on-year from 0.53% in Q1 2025, and up 18.34% quarter-over-quarter from 13.13% in Q4 2025.
NovoCure (NVCR) FCF Margin (2014 - 2026) Analysis & Trends
NovoCure has disclosed FCF Margin across 13 years of filings, most recently posting 10.73% for Q1 2026.
- FCF Margin for Q1 2026 came in at 10.73%, up 1913.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 7.13% (up 448.0% YoY), and the FY2025 annual result was 11.55%, down 11.0% from the prior year.
- FCF Margin came in at 10.73% for Q1 2026 at NovoCure, up from 13.13% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 12.76% in Q3 2022 to a low of 31.3% in Q1 2024.
- The 5-year median for FCF Margin is 10.73% (2026), against an average of 10.5%.
- Across the five-year window, FCF Margin sank 3363 bps in 2023 and jumped 2067 bps in 2024, its largest moves.
- NovoCure's FCF Margin stood at 7.89% in 2022, then plunged by 102 bps to 15.98% in 2023, then surged by 52 bps to 7.68% in 2024, then plunged by 71 bps to 13.13% in 2025, then grew by 18 bps to 10.73% in 2026.
- The last three FCF Margin figures came in at 10.73% (Q1 2026), 13.13% (Q4 2025), and 8.92% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 8.20% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 6.89% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 25.51% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 3.29% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -1.28% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.68% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 37.67% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 3.98% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 15.44% |
| 10 | NovoCure | 1.63 Bn | 1.20 Bn | 135.13 Mn | -10.73% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.73% |
| Dec 31, 2025 | -13.13% |
| Sep 30, 2025 | 8.92% |
| Jun 30, 2025 | -13.49% |
| Mar 31, 2025 | -29.86% |
| Dec 31, 2024 | -7.68% |
| Sep 30, 2024 | -0.20% |
| Jun 30, 2024 | -8.76% |
| Mar 31, 2024 | -31.30% |
| Dec 31, 2023 | -15.98% |
| Sep 30, 2023 | -20.87% |
| Jun 30, 2023 | -23.54% |
| Mar 31, 2023 | -18.67% |
| Dec 31, 2022 | -7.89% |
| Sep 30, 2022 | 12.76% |
| Jun 30, 2022 | 8.26% |
| Mar 31, 2022 | -6.38% |
| Dec 31, 2021 | 0.10% |
| Sep 30, 2021 | 15.79% |
| Jun 30, 2021 | 17.64% |